These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 19465231)

  • 1. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
    Ray KK; Seshasai SR; Wijesuriya S; Sivakumaran R; Nethercott S; Preiss D; Erqou S; Sattar N
    Lancet; 2009 May; 373(9677):1765-72. PubMed ID: 19465231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.
    Boussageon R; Bejan-Angoulvant T; Saadatian-Elahi M; Lafont S; Bergeonneau C; Kassaï B; Erpeldinger S; Wright JM; Gueyffier F; Cornu C
    BMJ; 2011 Jul; 343():d4169. PubMed ID: 21791495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J
    BMJ; 2011 Nov; 343():d6898. PubMed ID: 22115901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes.
    Kunutsor SK; Balasubramanian VG; Zaccardi F; Gillies CL; Aroda VR; Seidu S; Khunti K
    Diabetes Obes Metab; 2024 Jun; 26(6):2069-2081. PubMed ID: 38409644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials.
    Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K
    Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Marso SP; Kennedy KF; House JA; McGuire DK
    Diab Vasc Dis Res; 2010 Apr; 7(2):119-30. PubMed ID: 20382775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2011 Jun; (6):CD008143. PubMed ID: 21678374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive glucose control and cardiovascular outcomes in type 2 diabetes.
    Macisaac RJ; Jerums G
    Heart Lung Circ; 2011 Oct; 20(10):647-54. PubMed ID: 20807681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legacy Effect of Intensive Blood Glucose Control on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Very High Risk or Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized Controlled Trials.
    Zhang X; Liu Y; Zhang F; Li J; Tong N
    Clin Ther; 2018 May; 40(5):776-788.e3. PubMed ID: 29656857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression.
    Maiorino MI; Longo M; Scappaticcio L; Bellastella G; Chiodini P; Esposito K; Giugliano D
    Cardiovasc Diabetol; 2021 Oct; 20(1):210. PubMed ID: 34663316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intensive interventions compared to standard care in people with type 2 diabetes and microalbuminuria on risk factors control and cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials.
    Usman M; Gillies CL; Khunti K; Davies MJ
    Diabetes Res Clin Pract; 2018 Dec; 146():76-84. PubMed ID: 30312714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of intensive glucose lowering on cardiovascular outcomes.
    ; Gerstein HC; Miller ME; Genuth S; Ismail-Beigi F; Buse JB; Goff DC; Probstfield JL; Cushman WC; Ginsberg HN; Bigger JT; Grimm RH; Byington RP; Rosenberg YD; Friedewald WT
    N Engl J Med; 2011 Mar; 364(9):818-28. PubMed ID: 21366473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ojo O; Ojo OO; Adebowale F; Wang XH
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legacy effect of intensive glucose control on major adverse cardiovascular outcome: Systematic review and meta-analyses of trials according to different scenarios.
    Prattichizzo F; de Candia P; De Nigris V; Nicolucci A; Ceriello A
    Metabolism; 2020 Sep; 110():154308. PubMed ID: 32628943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials.
    Tkác I
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S57-62. PubMed ID: 20115934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycaemic control and the risk of mortality in elderly type 2 diabetic patients (ZODIAC-20).
    van Hateren KJ; Landman GW; Kleefstra N; Drion I; Groenier KH; Houweling ST; Bilo HJ
    Int J Clin Pract; 2011 Apr; 65(4):415-9. PubMed ID: 21401830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic control and cardiovascular events in diabetic hemodialysis patients.
    Drechsler C; Krane V; Ritz E; März W; Wanner C
    Circulation; 2009 Dec; 120(24):2421-8. PubMed ID: 19948978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.